Correlation Between Haleon Plc and OWC Pharmaceutical

Can any of the company-specific risk be diversified away by investing in both Haleon Plc and OWC Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Haleon Plc and OWC Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Haleon plc and OWC Pharmaceutical Research, you can compare the effects of market volatilities on Haleon Plc and OWC Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Haleon Plc with a short position of OWC Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Haleon Plc and OWC Pharmaceutical.

Diversification Opportunities for Haleon Plc and OWC Pharmaceutical

-0.32

Correlation Coefficient

Haleon Plc  OWC Pharmaceutical

Very good diversification

The 3 months correlation between Haleon and OWC is -0.32. Overlapping area represents the amount of risk that can be diversified away by holding Haleon plc and OWC Pharmaceutical Research in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on OWC Pharmaceutical and Haleon Plc is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Haleon plc are associated (or correlated) with OWC Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of OWC Pharmaceutical has no effect on the direction of Haleon Plc i.e., Haleon Plc and OWC Pharmaceutical go up and down completely randomly.

Pair Corralation between Haleon Plc and OWC Pharmaceutical

Assuming the 90 days horizon Haleon plc is expected to under-perform the OWC Pharmaceutical. But the pink sheet apears to be less risky and, when comparing its historical volatility, Haleon plc is 187.38 times less risky than OWC Pharmaceutical. The pink sheet trades about -0.04 of its potential returns per unit of risk. The OWC Pharmaceutical Research is currently generating about 0.33 of returns per unit of risk over similar time horizon. If you would invest  0.01  in OWC Pharmaceutical Research on September 3, 2024 and sell it today you would earn a total of  0.00  from holding OWC Pharmaceutical Research or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	98.46%
Values	Daily Returns

Haleon plc  vs.  OWC Pharmaceutical Research

Haleon plc

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Haleon plc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable fundamental indicators, Haleon Plc is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

OWC Pharmaceutical

Risk-Adjusted Performance

26 of 100

Strong

Compared to the overall equity markets, risk-adjusted returns on investments in OWC Pharmaceutical Research are ranked lower than 26 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak fundamental indicators, OWC Pharmaceutical reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Haleon Plc and OWC Pharmaceutical

The main advantage of trading using opposite Haleon Plc and OWC Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Haleon Plc position performs unexpectedly, OWC Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OWC Pharmaceutical will offset losses from the drop in OWC Pharmaceutical's long position.

The idea behind Haleon plc and OWC Pharmaceutical Research pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.